Gå ubegrenset med Magzter GOLD
Få ubegrenset tilgang til over 9000 magasiner, aviser og premiumhistorier for bare
Prøve GULL - Gratis
Eli Lilly ties up with Cipla for weight loss drug in new name
Mint Mumbai
|October 24, 2025
Eli Lilly's idea behind roping in Cipla is to penetrate markets which are currently beyond its reach
US drugmaker Eli Lilly has struck a deal with domestic drug giant Cipla Ltd to widen the reach of its blockbuster weight loss drug tirzepatide, doubling down on India's booming market ahead of an impending wave of anti-obesity generics.
Eli Lilly, which already sells its weight loss drug in India under the Mounjaro brand, will supply the drug to Cipla, which will promote and retail it under a second brand name, Yurpeak. Both drugs will cost the same.
Yurpeak will be available as a once-weekly pre-filled injector pen with four doses each, same as Lilly's Mounjaro Kwikpen, allowing healthcare providers to personalize treatment plans to individual patient needs.
Denne historien er fra October 24, 2025-utgaven av Mint Mumbai.
Abonner på Magzter GOLD for å få tilgang til tusenvis av kuraterte premiumhistorier og over 9000 magasiner og aviser.
Allerede abonnent? Logg på
FLERE HISTORIER FRA Mint Mumbai
Mint Mumbai
Dalmia puts Plan B in action as battle for Jaypee assets heats up
Dalmia Bharat Ltd has initiated the process of buying land in Rajasthan’s Jaisalmer for a new plant, even as it pursues the acquisition of Jaiprakash Associates Ltd’s cement assets, according to managing director and chief executive Puneet Dalmia.
2 mins
October 25, 2025
Mint Mumbai
Conglomerates strike a gold mine in land assets
A surge in property prices after the covid pandemic has made real estate an attractive opportunity for Indian conglomerates, which are rapidly expanding their realty businesses.
3 mins
October 25, 2025
Mint Mumbai
Cheap farm goods spark search for a rescue plan
The Centre is working on a contingency plan to prevent distress sales during the ongoing procurement season, at a time when crop prices have slipped below the minimum support price (MSP) in many states.
1 mins
October 25, 2025
Mint Mumbai
Manufacturing mission to get ₹10,000 cr reboot
Goal is to finance greenfield projects, scale high-value sectors in seven regions
2 mins
October 25, 2025
Mint Mumbai
Folk tales and everyday horror
If you have any association with hill towns, you're likely to have grown up with stories that send shivers down the spine.
1 mins
October 25, 2025
Mint Mumbai
Blackstone to pick up 9.99% in Federal Bank for ₹6,197 cr
Global investor to buy nearly 10% stake in Kerala-based lender
2 mins
October 25, 2025
Mint Mumbai
Piyush Pandey and the art of connecting with India’s masses
In a casual banter at an industry event in 2008, this writer asked a bunch of young executives from India's advertising industry if they felt overwhelmed in the presence of creative legends from all over the world at an international event that they had just returned from.
3 mins
October 25, 2025
Mint Mumbai
Mysuru brews a fresh café culture
The city's classic flavours intermingle with bakeries and cafes as migration and changing work habits bring new customers
3 mins
October 25, 2025
Mint Mumbai
Branded mkts lift Dr Reddy’s in Q2
Dr Reddy’s Laboratories beat street estimates in the September quarter, with a revenue of ₹8,805 crore and profit after tax of ₹1,437 crore, buoyed by growth in branded markets and its nicotine replacement therapy (NRT) portfolio.
1 min
October 25, 2025
Mint Mumbai
Thunder, lightning and rain in Angkor Wat
Visiting Cambodia in the monsoon reveals unexpected joys and the country’s foundational links with water
5 mins
October 25, 2025
Listen
Translate
Change font size